ELVN Operating Cash Flow (Statement)
Enliven Therapeutics Inc · Operating Cash Flow (Statement)
ELVN Operating Cash Flow (Statement)
Latest reported-$66.94Mperiod ending
ELVN TTM Cash from Operations (-$21.88M → -$66.94M)
TTM operating cash flow (statement)
High-resolution chart · PNG
ELVN operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -66,939,000 | |
| -65,465,000 | |
| -70,301,000 | |
| -71,666,000 | |
| -70,580,000 | |
| -73,958,000 | |
| -73,192,000 | |
| -68,471,000 | |
| -72,172,000 | |
| -63,786,000 | |
| -61,269,000 | |
| -56,932,000 | |
| -47,485,000 | |
| -42,560,000 | |
| -32,077,000 | |
| -36,417,000 | |
| -40,871,000 | |
| -44,112,000 | |
| -46,771,000 | |
| -42,555,000 | |
| -42,000,000 | |
| -40,891,000 | |
| -37,398,000 | |
| -37,171,000 | |
| -33,105,000 | |
| -28,997,000 | |
| -21,877,000 |